Fundamental leadership · SEC EDGAR · no analyst estimates · as of 2026-07-20
Which industries lead on earnings and sales, today. As of 2026-07-20, 4,463 companies clear the eligibility gates and 1,339 rank Leader or Strong on filed EPS and revenue growth. The strongest industry group is Precious Metals with 29 Leader or Strong names. 19.4% of eligible companies also sit in the top relative-strength quintile — fundamentals and price agreeing.
Industry / Healthcare
| Ticker | Company | Rank | Δ3wk | Verdict | EPS YoY | Sales YoY | Margin Δ | 6M RS | Filed |
|---|---|---|---|---|---|---|---|---|---|
| NIVF | NewGenIvf Group Limited Class A ordinary shares | 99 | ±0 | Leader | to profit | >+999% | — | 2 | 2026-03-31 |
| BLLN | BillionToOne, Inc. Class A Common Stock | 96 | ±0 | Leader | to profit | +100% | — | 85 | 2026-05-06 |
| CAI | Caris Life Sciences, Inc. Common Stock | 96 | +1 | Leader | to profit | +79% | — | 16 | 2026-05-08 |
| OMDA | Omada Health, Inc. Common Stock | 94 | +1 | Leader | loss narrowed 96% | +42% | — | 92 | 2026-05-08 |
| VCYT | Veracyte, Inc.Biotech & Genomics | 93 | ±0 | Leader | +289% | +21%↑ | +919 bps | 88 | 2026-05-06 |
| BTSG | BrightSpring Health Services, Inc. Common Stock | 92 | ±0 | Leader | +379% | +26%↑ | +53 bps | 95 | 2026-05-01 |
| LFST | LifeStance Health Group, Inc. Common Stock | 91 | ±0 | Leader | to profit | +21%↑ | +403 bps | 92 | 2026-05-07 |
| NTRA | Natera, Inc. Common Stock | 91 | ±0 | Leader | loss widened 20% | +39% | -56 bps | 66 | 2026-05-08 |
| AVAH | Aveanna Healthcare Holdings Inc. Common Stock | 90 | ±0 | Leader | +533%↑ | +16% | +363 bps | 52 | 2026-05-14 |
| PACS | PACS Group, Inc. | 89 | ±0 | Strong | +194% | +11%↓ | +464 bps | 71 | 2026-05-11 |
| PRVA | Privia Health Group, Inc. Common Stock | 89 | +1 | Strong | -33% | +26% | +44 bps | 67 | 2026-05-07 |
| PNTG | The Pennant Group, Inc. Common Stock | 88 | ±0 | Strong | +9% | +36% | -12 bps | 87 | 2026-05-06 |
| TOI | The Oncology Institute, Inc. Common Stock | 83 | ±0 | Strong | loss narrowed 90%↑ | +41% | +692 bps | 94 | 2026-05-07 |
| CCM | Concord Medical Services Holding Limited | 81 | ±0 | Strong | loss narrowed 70% | +21% | +8451 bps | 45 | 2026-04-29 |
| NHC | National Healthcare Corp. | 80 | ±0 | Strong | +10% | +2%↓ | +119 bps | 93 | 2026-05-07 |
| VMD | Viemed Healthcare, Inc. Common Shares | 80 | ±0 | Strong | 0% | +28%↑ | -23 bps | 93 | 2026-05-05 |
| SHC | Sotera Health Company Common Stock | 79 | ±0 | Strong | to profit | +10% | +928 bps | 42 | 2026-05-05 |
| CON | Concentra Group Holdings Parent, Inc. | 78 | ±0 | Strong | +30% | +14%↓ | -37 bps | 90 | 2026-05-07 |
| ADUS | Addus HomeCare Corp. | 77 | ±0 | Strong | +17% | +8% | +77 bps | 56 | 2026-05-05 |
| CDNA | CareDx, Inc. | 74 | ±0 | Strong | to profit | +39%↑ | -1742 bps | 96 | 2026-04-28 |
| ENSG | The Ensign Group, Inc. | 74 | ±0 | Strong | +22%↑ | +18%↓ | +3 bps | 46 | 2026-04-30 |
| TALK | Talkspace, Inc. Common Stock | 74 | -1 | Strong | to loss | +18% | +252 bps | 87 | 2026-05-11 |
| HCSG | Healthcare Services Group | 72 | ±0 | Strong | +61%↓ | +3%↓ | +105 bps | 84 | 2026-04-24 |
| GH | Guardant Health, Inc. Common StockBiotech & Genomics | 70 | ±0 | Strong | loss widened 10% | +48%↑ | +1735 bps | 85 | 2026-05-07 |
| UHS | Universal Health Services, Inc. Class B | 70 | ±0 | Strong | +18%↓ | +10% | +63 bps | 27 | 2026-05-07 |
| THC | Tenet Healthcare Corporation New | 69 | +1 | Average | +88%↑ | +3% | +38 bps | 49 | 2026-04-30 |
| EHC | Encompass Health Corporation Common Stock | 68 | ±0 | Average | +30%↑ | +9% | +78 bps | 66 | 2026-05-01 |
| XGN | Exagen Inc. Common Stock | 67 | ±0 | Average | loss narrowed 15%↑ | +12%↓ | +403 bps | 49 | 2026-05-11 |
| FMS | Fresenius Medical Care AG | 63 | ±0 | Average | +414%↑ | -4% | +260 bps | 69 | 2026-02-24 |
| PGNY | Progyny, Inc. Common Stock | 63 | ±0 | Average | +71% | +1%↓ | +144 bps | 85 | 2026-05-08 |
| SGRY | Surgery Partners, Inc. Common Stock | 60 | ±0 | Average | loss narrowed 7% | +4% | +122 bps | 54 | 2026-05-05 |
| DVA | DaVita Inc. | 59 | ±0 | Average | +44%↑ | +6% | -69 bps | 97 | 2026-05-05 |
| HCA | HCA Healthcare, Inc. | 58 | ±0 | Average | +11% | +4%↓ | +80 bps | 29 | 2026-04-29 |
| LFMD | LifeMD, Inc. Common Stock | 58 | ±0 | Average | loss widened 900% | -22% | -589 bps | 72 | 2026-05-06 |
| MDXH | MDxHealth SA Ordinary Shares | 58 | ±0 | Average | loss narrowed 42% | +20% | +1410 bps | 3 | 2026-04-03 |
| OPCH | Option Care Health, Inc. Common Stock | 56 | ±0 | Average | +4% | +1% | -67 bps | 18 | 2026-04-30 |
| GRAL | GRAIL, Inc. Common Stock | 55 | ±0 | Average | loss narrowed 26% | +28% | >+10,000 bps | 24 | 2026-05-07 |
| MGRX | Mangoceuticals, Inc. Common Stock | 55 | +1 | Average | loss narrowed 83% | -38% | — | 19 | 2026-05-19 |
| SRTA | Strata Critical Medical, Inc. Class A Common Stock | 54 | ±0 | Average | to profit | +24% | +414 bps | 40 | 2026-05-06 |
| BKD | Brookdale Senior Living, Inc. | 51 | ±0 | Average | loss narrowed 89%↑ | -6%↓ | -67 bps | 86 | 2026-05-07 |
| HIMS | Hims & Hers Health, Inc.GLP-1 / Obesity | 51 | +1 | Average | to loss | +4%↓ | -745 bps | 61 | 2026-05-11 |
| TDOC | Teladoc Health, Inc. | 51 | ±0 | Average | loss narrowed 32% | -2% | +3318 bps | 91 | 2026-04-30 |
| SBC | SBC Medical Group Holdings Incorporated Common Stock | 50 | +1 | Average | -48%↓ | -9%↑ | -1198 bps | 22 | 2026-05-14 |
| MD | Pediatrix Medical Group, Inc. | 49 | +1 | Average | +50% | +4%↑ | +1396 bps | 71 | 2026-05-05 |
| AIRS | AirSculpt Technologies, Inc. Common Stock | 48 | ±0 | Average | loss narrowed 40% | 0%↑ | +62 bps | 97 | 2026-05-08 |
| CSTL | Castle Biosciences, Inc. Common Stock | 48 | ±0 | Average | loss narrowed 46%↑ | -5% | -582 bps | 17 | 2026-05-06 |
| DGX | Quest Diagnostics Inc. | 48 | ±0 | Average | +15%↑ | +9% | +56 bps | 66 | 2026-04-22 |
| ACON | Aclarion, Inc. Common Stock | 47 | ±0 | Average | loss narrowed 86% | +11% | — | 20 | 2026-05-13 |
| EUDA | EUDA Health Holdings Limited Ordinary Shares | 46 | +1 | Average | loss widened 215% | +70% | — | 6 | 2026-04-28 |
| CYH | Community Health Systems, Inc. | 40 | ±0 | Average | loss widened 330% | -6%↓ | +738 bps | 46 | 2026-04-22 |
| LH | Labcorp Holdings Inc. | 40 | ±0 | Average | +33% | +6% | +189 bps | 61 | 2026-05-04 |
| RDNT | RadNet, Inc. Common Stock | 40 | ±0 | Average | loss narrowed 16% | +22%↑ | -80 bps | 34 | 2026-05-11 |
| SNDA | Sonida Senior Living, Inc. | 39 | +1 | Average | loss widened 210%↓ | +33% | -5120 bps | 82 | 2026-05-11 |
| BRTX | BioRestorative Therapies, Inc. Common Stock (NV) | 36 | ±0 | Average | loss narrowed 81%↑ | -7%↑ | — | 6 | 2026-05-14 |
| INNV | InnovAge Holding Corp. Common Stock | 36 | ±0 | Average | loss widened 175%↓ | +15% | +289 bps | 96 | 2026-05-08 |
| VSEE | VSee Health, Inc. Common Stock | 36 | ±0 | Average | loss narrowed 79%↓ | -5% | — | 4 | 2026-05-15 |
| AGL | agilon health, inc. | 34 | +1 | Average | +303% | -7% | -238 bps | 99 | 2026-05-06 |
| AMS | American Shared Hospital Services | 34 | ±0 | Average | loss narrowed 10%↓ | +16% | +269 bps | 23 | 2026-05-14 |
| BDSX | Biodesix, Inc. Common Stock | 34 | ±0 | Average | loss widened 913% | +42%↑ | +1785 bps | 98 | 2026-05-04 |
| WGS | GeneDx Holdings Corp. Class A Common Stock | 33 | ±0 | Average | loss widened 839%↓ | +17%↓ | -1064 bps | 15 | 2026-05-04 |
| CHE | Chemed Corporation | 32 | +1 | Average | 0%↑ | +2% | -271 bps | 69 | 2026-04-28 |
| PIII | P3 Health Partners Inc. Common Stock | 31 | +1 | Average | to profit↑ | +4% | +599 bps | 99 | 2026-05-14 |
| USPH | US Physical Therapy Inc | 30 | ±0 | Average | to loss | +8%↓ | +20 bps | 36 | 2026-05-08 |
| ARDT | Ardent Health, Inc. | 29 | ±0 | Laggard | -3%↑ | +7% | -186 bps | 74 | 2026-05-06 |
| YDES | YD Bio Limited Ordinary Shares | 29 | ±0 | Laggard | loss widened 500% | +17% | — | 4 | 2026-04-30 |
| SERA | Sera Prognostics, Inc. Class A Common Stock | 27 | ±0 | Laggard | loss narrowed 15% | -63%↓ | — | 17 | 2026-05-06 |
| CCEL | Cryo-Cell International Inc. | 21 | +6 | Laggard | +75%↑ | -2% | -1226 bps | 56 | new filing |
| PSNL | Personalis, Inc. Common StockBiotech & Genomics | 20 | ±0 | Laggard | loss widened 61%↓ | -25% | -8063 bps | 88 | 2026-05-07 |
| ACHC | Acadia Healthcare Company, Inc. | 18 | ±0 | Laggard | -44% | +8%↑ | -3982 bps | 98 | 2026-04-30 |
| FTRE | Fortrea Holdings Inc. Common Stock | 17 | ±0 | Laggard | loss narrowed 96%↑ | -2% | +1086 bps | 68 | 2026-05-05 |
| AHCO | AdaptHealth Corp. Common Stock | 16 | ±0 | Laggard | loss widened 140% | +5% | -505 bps | 59 | 2026-05-05 |
| FLGT | Fulgent Genetics, Inc. Common Stock | 16 | ±0 | Laggard | loss widened 116% | -3%↓ | -847 bps | 23 | 2026-05-01 |
| ATPC | Agape ATP Corporation Common Stock | 7 | ±0 | Laggard | loss widened 371% | -5%↓ | — | 11 | 2026-05-15 |
| BGLC | BioNexus Gene Lab Corp Common stock | 3 | ±0 | Laggard | loss widened 543% | -99%↓ | — | 9 | 2026-05-15 |
| DCGO | DocGo Inc. Common Stock | 2 | ±0 | Laggard | loss widened 67% | -21%↑ | -6034 bps | 27 | 2026-05-11 |
Every US common stock and ADR in the universe is ranked on fundamental growth from the numbers companies actually filed with the SEC — no analyst estimates, no forward projections. TickerStance reads EDGAR XBRL company facts directly.
To qualify, a company must have at least six quarters of EPS and revenue history available and the most-recent filing must be no older than 200 days. That gate keeps the rankings grounded in current operating conditions rather than stale data.
Two growth factors are computed: recent year-over-year growth (latest quarter vs the same quarter last year) blended with a three-year trend score. Both factors are percentile-ranked universe-wide so a rank of 90 means the company grows faster than 90% of its peers, regardless of absolute size. The two factor percentiles are then combined into a single 1-99 fundamentals rank.
Operating margin is tracked as context — a company whose margins are expanding while growing revenue is a stronger story than one shrinking margins to buy growth — but margin level is not a direct rank input. Industries, sectors, and themes inherit their rank from the median of their members, so a strong cluster is one where most constituent companies score well, not just a few outliers.
The RS overlap metric shows what share of a cluster's eligible companies sit in the top relative-strength quintile (6M RS rank ≥ 80). When a fundamentally strong group also carries broad price leadership, it has both the earnings story and the institutional sponsorship — the combination that historically precedes sustained outperformance.
Every US common stock and ADR with sufficient SEC filing history gets a 1-99 fundamentals rank: EPS and revenue growth factors are computed from filed XBRL data, percentile-ranked across the universe, and blended. Ranks of 90+ are Leaders, 70-89 Strong, 30-69 Average, below 30 Laggards. Industries, sectors, and themes are then ranked by their members' median rank.
SEC EDGAR XBRL company facts — the numbers companies actually filed. No analyst estimates, no forward guidance, no third-party data vendor.
Sign-aware: a narrowed loss counts as improvement, a widened loss as deterioration, a swing to profit as a turnaround. Conventional percent math misreads losses (a loss shrinking from -$0.12 to -$0.07 is improvement, not "down 42%"), so the table says "loss narrowed 42%" instead of printing a misleading percentage.
The change in a group's median fundamentals rank versus 15 and 30 trading days ago — the classic "improving group" read. Positive means the group is gaining rank. Dashes mean the history window isn't available yet.
Once per US trading day after the close. The as-of date in the header is the snapshot date.